Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017 Document date: 2017_11_7
ID: roslkxeq_703
Snippet: Disclosures: Disclosures to report. The authors declare a potential conflict of interest with the company Echosens that developed the blood score described in this study. Echosens supports part of the residency funding of the presenting author. Increased serum bile acids (SBA) can be expected with hepatic, biliary or portal disorders that limit hepatic portal blood flow or hepatocellular uptake. Best clinicopathologic tests detecting those disord.....
Document: Disclosures: Disclosures to report. The authors declare a potential conflict of interest with the company Echosens that developed the blood score described in this study. Echosens supports part of the residency funding of the presenting author. Increased serum bile acids (SBA) can be expected with hepatic, biliary or portal disorders that limit hepatic portal blood flow or hepatocellular uptake. Best clinicopathologic tests detecting those disorders remain controversial.
Search related documents:
Co phrase search for related documents- bile acid and serum bile acid: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- blood flow and portal blood flow: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- blood flow and study describe: 1, 2, 3
- blood score and study describe: 1
- controversial remain and disorder detect: 1
Co phrase search for related documents, hyperlinks ordered by date